• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测肺量计检查受限情况的机器学习模型的开发与外部验证

Development and External Validation of a Machine Learning Model to Predict Restriction from Spirometry.

作者信息

Moffett Alexander T, Balasubramanian Aparna, McCormack Meredith C, Aysola Jaya, Ungar Lyle H, Halpern Scott D, Weissman Gary E

机构信息

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Palliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

medRxiv. 2025 Jan 14:2025.01.02.25319890. doi: 10.1101/2025.01.02.25319890.

DOI:10.1101/2025.01.02.25319890
PMID:39802801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11722487/
Abstract

BACKGROUND

Though European Respiratory Society and American Thoracic Society (ERS/ATS) guidelines for pulmonary function test (PFT) interpretation recommend the use of the forced vital capacity (FVC) lower limit of normal (LLN) to exclude restriction, recent data suggest that the negative predictive value (NPV) of the FVC LLN is lower than has been accepted, particularly among non-Hispanic Black patients. We sought to develop and externally validate a machine learning (ML) model to predict restriction from spirometry and determine whether its use may improve the accuracy and equity of PFT interpretation.

METHODS

We included PFTs with both static and dynamic lung volume measurements for patients between 18 and 80 years of age who were tested at pulmonary diagnostic labs within two health systems. We used PFTs from one health system to train logistic regression, random forest, and boosted tree models to predict restriction using demographic, anthropometric, and spirometric data. We used PFTs from the second health system to externally validate these models. The primary measure of model performance was the NPV. Racial equity was assessed by comparing the NPV among non-Hispanic Black and non-Hispanic White patients.

FINDINGS

A total of 42 462 PFTs were used for model development and 24 524 for external validation. The prevalence of restriction was 29.8% in the development dataset and 39.6% in the validation dataset. All three ML models outperformed the FVC LLN by a wide margin, both overall and among all demographic subgroups. The overall NPV of the random forest model (88.3%, 95% confidence interval [CI] 87.8% to 88.9%) was significantly greater than that of the FVC LLN (72.7%, 95% CI 72.1% to 73.3%). The NPV of the random forest model was greater than that of the FVC LLN among both non-Hispanic Black (74.6% [95% CI 72.5% to 76.6%] versus 49.5% [95% CI 47.8% to 51.2%]) and non-Hispanic White (90.9% [95% CI 90.3% to 91.5%] versus 79.6% [95% CI 78.9% to 80.3%]) patients.

INTERPRETATION

ML models to exclude restriction from spirometry improve the accuracy and equity of PFT interpretation but do not fully eliminate racial differences.

摘要

背景

尽管欧洲呼吸学会和美国胸科学会(ERS/ATS)关于肺功能测试(PFT)解读的指南推荐使用正常预计值下限(LLN)的用力肺活量(FVC)来排除限制,但最近的数据表明,FVC LLN的阴性预测值(NPV)低于以往公认的值,尤其是在非西班牙裔黑人患者中。我们试图开发并外部验证一种机器学习(ML)模型,以通过肺活量测定预测限制,并确定其使用是否可以提高PFT解读的准确性和公平性。

方法

我们纳入了在两个医疗系统内的肺诊断实验室接受测试的18至80岁患者的同时进行静态和动态肺容积测量的PFT。我们使用来自一个医疗系统的PFT来训练逻辑回归、随机森林和增强树模型,以使用人口统计学、人体测量学和肺活量测定数据预测限制。我们使用来自第二个医疗系统的PFT对这些模型进行外部验证。模型性能的主要指标是NPV。通过比较非西班牙裔黑人和非西班牙裔白人患者的NPV来评估种族公平性。

结果

共有42462份PFT用于模型开发,24524份用于外部验证。在开发数据集中限制的患病率为29.8%,在验证数据集中为39.6%。所有三种ML模型在总体上以及所有人口统计学亚组中均大幅优于FVC LLN。随机森林模型的总体NPV(88.3%,95%置信区间[CI]87.8%至88.9%)显著高于FVC LLN(72.7%,95%CI 72.1%至73.3%)。在非西班牙裔黑人(74.6%[95%CI 72.5%至76.6%]对49.5%[95%CI 47.8%至51.2%])和非西班牙裔白人(90.9%[95%CI 90.3%至91.5%]对79.6%[95%CI 78.9%至80.3%])患者中,随机森林模型的NPV均高于FVC LLN。

解读

用于通过肺活量测定排除限制的ML模型提高了PFT解读的准确性和公平性,但并未完全消除种族差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c881/11745120/4e4ae8e2fedf/nihpp-2025.01.02.25319890v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c881/11745120/d307eb983b81/nihpp-2025.01.02.25319890v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c881/11745120/4e4ae8e2fedf/nihpp-2025.01.02.25319890v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c881/11745120/d307eb983b81/nihpp-2025.01.02.25319890v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c881/11745120/4e4ae8e2fedf/nihpp-2025.01.02.25319890v2-f0002.jpg

相似文献

1
Development and External Validation of a Machine Learning Model to Predict Restriction from Spirometry.用于预测肺量计检查受限情况的机器学习模型的开发与外部验证
medRxiv. 2025 Jan 14:2025.01.02.25319890. doi: 10.1101/2025.01.02.25319890.
2
A Normal Forced Vital Capacity Does Not Reliably or Equitably Exclude Restriction.正常的用力肺活量并不能可靠或公平地排除限制。
medRxiv. 2024 Oct 23:2024.10.22.24315945. doi: 10.1101/2024.10.22.24315945.
3
The utility of spirometry in diagnosing pulmonary restriction.肺量计在诊断肺限制性疾病中的应用。
Lung. 2008 Jan-Feb;186(1):19-25. doi: 10.1007/s00408-007-9052-8. Epub 2007 Nov 8.
4
The role of growth and nutrition in the early origins of spirometric restriction in adult life: a longitudinal, multicohort, population-based study.生长和营养在成人生活中肺功能受限的早期起源中的作用:一项纵向、多队列、基于人群的研究。
Lancet Respir Med. 2022 Jan;10(1):59-71. doi: 10.1016/S2213-2600(21)00355-6. Epub 2021 Nov 26.
5
Accuracy of spirometry in diagnosing pulmonary restriction in elderly people.肺量计在诊断老年人肺部限制中的准确性。
J Am Geriatr Soc. 2009 Nov;57(11):2107-11. doi: 10.1111/j.1532-5415.2009.02525.x. Epub 2009 Sep 30.
6
Outcome-based Definition of the Lower Limit of Normal in Spirometry: A Study of 26,000 Young Adult Men.基于结果的肺量计正常下限定义:一项对 26000 名成年男性的研究。
Ann Am Thorac Soc. 2024 Sep;21(9):1261-1271. doi: 10.1513/AnnalsATS.202312-1027OC.
7
Evaluating How Post-Bronchodilator Vital Capacities Affect the Diagnosis of Obstruction in Pulmonary Function Tests.评估支气管扩张剂后肺活量如何影响肺功能测试中阻塞性疾病的诊断。
Respir Care. 2016 Nov;61(11):1523-1529. doi: 10.4187/respcare.04611. Epub 2016 Sep 13.
8
COPD in chronic heart failure: less common than previously thought?慢性心力衰竭合并 COPD:比以前认为的更少见?
Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.
9
Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity.用力肺活量和6秒用力呼气量作为预测肺总量降低的指标。
Eur Respir J. 2008 Feb;31(2):391-5. doi: 10.1183/09031936.00032307. Epub 2007 Oct 10.
10
FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction.在肺量计检测气道阻塞和受限中,FEV1/FEV6以及FEV6作为FEV1/FVC和FVC的替代指标。
Chest. 2005 May;127(5):1560-4. doi: 10.1378/chest.127.5.1560.

本文引用的文献

1
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.TRIPOD+AI 声明:报告使用回归或机器学习方法的临床预测模型的更新指南。
BMJ. 2024 Apr 16;385:e078378. doi: 10.1136/bmj-2023-078378.
2
Evaluation of clinical prediction models (part 2): how to undertake an external validation study.临床预测模型的评估(第 2 部分):如何进行外部验证研究。
BMJ. 2024 Jan 15;384:e074820. doi: 10.1136/bmj-2023-074820.
3
Predicting total lung capacity from spirometry: a machine learning approach.
通过肺量计预测肺总量:一种机器学习方法。
Front Med (Lausanne). 2023 May 19;10:1174631. doi: 10.3389/fmed.2023.1174631. eCollection 2023.
4
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.肺功能测试解读中的种族和民族差异:美国胸科学会官方声明。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):978-995. doi: 10.1164/rccm.202302-0310ST.
5
Deep learning using multilayer perception improves the diagnostic acumen of spirometry: a single-centre Canadian study.深度学习使用多层感知提高肺功能检查的诊断敏锐度:一项单中心加拿大研究。
BMJ Open Respir Res. 2022 Dec;9(1). doi: 10.1136/bmjresp-2022-001396.
6
A Race-neutral Approach to the Interpretation of Lung Function Measurements.一种不基于种族的解读肺功能测量的方法。
Am J Respir Crit Care Med. 2023 Mar 15;207(6):768-774. doi: 10.1164/rccm.202205-0963OC.
7
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准:常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
8
Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?机器学习在肺功能评估中的应用:我们现在何处,又将走向何方?
Front Physiol. 2021 Jun 24;12:678540. doi: 10.3389/fphys.2021.678540. eCollection 2021.
9
Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry.ERS 官方技术标准:欧洲血统个体静态肺容量的全球肺功能倡议参考值。
Eur Respir J. 2021 Mar 11;57(3). doi: 10.1183/13993003.00289-2020. Print 2021 Mar.
10
Applications of artificial intelligence and machine learning in respiratory medicine.人工智能和机器学习在呼吸医学中的应用。
Thorax. 2020 Aug;75(8):695-701. doi: 10.1136/thoraxjnl-2020-214556. Epub 2020 May 14.